Gateway 2012: FOSS NIRSystems, Inc - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

Gateway 2012: FOSS NIRSystems, Inc



Your online Gateway to FOSS NIRSystems, Inc. in 2012

7703 Montpelier Road
Laurel, MD 20723
USA
Phone: +1-301-680-9600 / 1-800-343-2036
Fax: +1-301-236-0134

info@foss-nirsystems.com
www.foss-nirsystems.com

About FOSS NIRSystems, Inc.:

 

FOSS NIRSystems, Inc. is a unit of FOSS A/S of Denmark and the world's leading supplier of scanning near-infrared (NIR) products and services. We have over 45 years of industry experience and more than 18,000 successful installations worldwide. Headquartered in Laurel, MD, FOSS NIRSystems designs and manufactures a complete range of rapid scanning NIR spectrophotometers for laboratory and process applications. Sales, service, and support offices are located worldwide to serve our customers in the best possible way. For more information about FOSS NIRSystems and our complete product line, please contact us.


 
FOSS NIRSystems will exhibit at several shows during 2012, including:

Pittcon, Orlando, March, booth: 2509
Interphex, NYC, May, booth: 2072
SupplySide Marketplace, NYC, May, booth: 475
AAPS Annual Meeting, Chicago, October, booth: 4604
SupplySide West, Las Vegas, November, booth: 26091
EAS, NJ, November, booth: 201/203

 

New Products
and Releases
New Whitepapers

For our latest press releases, please visit: http://www.foss-nirsystems.com/news_latest.html

For FOSS pharmaceutical white papers, please visit: http://www.foss-nirsystems.com/pharmaceuticals.html

 

 

Please visit us at our booth or schedule a meeting at the show by contacting us at info@foss-nirsystems.com or by phone.

 



ADVERTISEMENT

blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
FDASIA was signed into law two years ago. Where has the most progress been made in implementation?
Reducing drug shortages
Breakthrough designations
Protecting the supply chain
Expedited reviews of drug submissions
More stakeholder involvement
Reducing drug shortages
27%
Breakthrough designations
9%
Protecting the supply chain
41%
Expedited reviews of drug submissions
9%
More stakeholder involvement
14%
View Results
Jim Miller Outsourcing Outlook Jim Miller Health Systems Raise the Bar on Reimbursing New Drugs
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerThe Mainstreaming of Continuous Flow API Synthesis
Jill Wechsler Regulatory Watch Jill Wechsler Industry Seeks Clearer Standards for Track and Trace
Siegfried Schmitt Ask the Expert Siegfried SchmittData Integrity
Sandoz Wins Biosimilar Filing Race
NIH Translational Research Partnership Yields Promising Therapy
Clusters set to benefit from improved funding climate but IP rights are even more critical
Supplier Audit Program Marks Progress
FDA, Drug Companies Struggle with Compassionate Use Requests

Click here